Untangling Why DHA Doesn’t Always Help in Alzheimer’s Studies
This review explains why DHA's promising mechanisms in Alzheimer's disease haven't consistently translated into clear clinical trial benefits.
A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
This review explains why DHA's promising mechanisms in Alzheimer's disease haven't consistently translated into clear clinical trial benefits.
A review of gastrointestinal cancer surgery patients finds immunonutrition (including omega-3s) most consistently reduces postoperative infections in nutritionally at-risk patients, though effects on recovery and survival remain unclear.
In heart attack survivors, a marker of the body's own fat-production activity was linked to faster kidney decline, more fatty liver, and higher cardiovascular death risk.
Across 20 trials, omega-3 more consistently reduced arterial stiffness at higher doses (1.8-4g/day) taken for 12+ weeks, especially in higher-risk populations.
A narrative review finds omega-3, vitamin D3, and vitamin K2 share biological pathways linking heart, brain, and bone aging, but no trial has proven the combination beats individual nutrients or placebo.
Krill oil's phospholipid-bound omega-3s, low contaminant profile, and added nutrients like choline and astaxanthin may support multiple aspects of healthy aging.